Sarepta Therapeutics

+$1.19 (+1.43%) Today

-$0.29 (-0.34%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRPT and other ETFs, options, and stocks.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

CEO

Douglas S. Ingram

Employees

866

Headquarters

Cambridge, Massachusetts

Founded

1980

SRPT Key Statistics

Market Cap

6.72B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.70M

High Today

$85.75

Low Today

$82.50

Open Price

$83.16

Volume

1.90M

52 Week High

$181.83

52 Week Low

$65.30

SRPT News

Benzinga15h

Expert Ratings For Sarepta Therapeutics - Sarepta Therapeutics

Over the past 3 months, 6 analysts have published their opinion on Sarepta Therapeutics (NASDAQ:SRPT) stock. These analysts are typically employed by large Wall

Analyst Ratings

67%

of 21 ratings

Buy

66.7%

Hold

33.3%

Sell

SRPT Earnings

-$1.84

-$1.23

-$0.61

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 4, After Hours

Why Robinhood?

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA. View more

Expert Ratings For Sarepta Therapeutics - Sarepta Therapeutics

67%

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.